Logo image
Epidemiology of metabolic syndrome in patients with inflammatory bowel disease: a population-level cohort study from the United States
Journal article   Peer reviewed

Epidemiology of metabolic syndrome in patients with inflammatory bowel disease: a population-level cohort study from the United States

Aakash Desai, Himsikhar Khataniar, Jana G. Hashash, Priya Sehgal, Francis A. Farraye and Gursimran S. Kochhar
Annals of gastroenterology, v 38(6), pp 1-11
10 Oct 2025
url
https://doi.org/10.20524/aog.2025.1011View
Published, Version of Record (VoR) Open

Abstract

Gastroenterology & Hepatology Life Sciences & Biomedicine Science & Technology
Background Epidemiological data on metabolic syndrome (MetS) in patients with inflammatory bowel disease (IBD) are limited. Methods A retrospective cohort study was conducted using the United States (US) Collaborative Network (TriNetX) to obtain data for patients with IBD between 2010 and 2023. The primary aim of the study was to estimate the prevalence of MetS in ulcerative colitis (UC) and Crohn's disease (CD). Prevalence was further characterized by age, sex, race, disease location, IBD medications, history of surgery, and IBD phenotype. Results Among 100,890 patients with IBD, metabolic syndrome (MetS) affected 34.4% overall (UC 32.4%, CD 34.3%). Prevalence rose sharply with age (12-14% at 18-39 to 47-50% at >= 65) and was higher in men than women. Rates were greatest among American Indian (CD 45.2%), Black (40%) and Hispanic (38-39%) populations, and lowest in Asian patients (26%). MetS clustered with more severe phenotypes (stricturing CD, prior CD surgery) and was not elevated among patients receiving advanced therapy. MetS was associated with greater systemic corticosteroid use and higher surgery/colectomy risk, while stricture and fistula risks in CD were similar; advanced therapy was not initiated more frequently in CD. Conclusion Our study provides updated epidemiological estimates of MetS in patients with IBD in the US.

Metrics

3 Record Views

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Gastroenterology & Hepatology
Logo image